
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
Raw trajectory data (GROMACS format) of all atom molecular dynamics simulation of COVID-19 related SARS-CoV-2 dimeric main protease (based on PDB 6LU7) with 7 kinds of HIV inhibitors (darunavir, indinavir, lopinavir, nelfinavir, ritonavir, saquinavir, and tipranavir) were calculated on massively parallel supercomputer HOKUSAI Big Waterfall at RIKEN ISC, and a special-purpose computer, MDGRAPE-4A, at RIKEN BDR, JAPAN. For each ligand, 200ns length 28 trajectories were calculated. Some of these trajectories were calculated further longer. We can observe formation of encounter complex and investigate potential binding sites on the surface of the dimeric protease. We hope that these raw data are valuable for further drug repurposing/development research targeting the SARS-CoV-2 main protease. We will submit analysis of these data to refereed journal. Molecular dynamics simulations were performed under NVT at 310K, with the time step 2.5fs. The starting structure was prepared based on PDB 6LU7, with amber14sb force field in about 10nm cubic box with periodic boundary conditions. The ligands were initially placed apart from the active sites of the dimeric main protease. We have also already deposited 10 microseconds trajectories of the dimeric protease without ligand (with amber99sb-ildn force field) in the repository https://data.mendeley.com/datasets/vpps4vhryg/1 (DOI:10.17632/vpps4vhryg.1). Files: LIG_28traj200ns_every200ps.zip (28trajectories for each ligand) traj200ns_every200ps/LIG/a/traj200ns_every200ps_LIG-a-n.xtc (trajectory in GROMACS XTC) traj200ns_every200ps/LIG/a/conf.gro (initial condition in GROMACS GRO) traj200ns_every200ps/LIG/topology/ (contains topology files) traj200ns_every200ps/LIG/mdp/ (contains run paramter files) ZZZ_20traj1us_every200ps.zip (20trajectories extended to 1microsecond) traj1us_every200ps/traj1us_every200ps_LIG-a-n.xtc DAR-C-06, DAR-D-07 IND-C-05, IND-C-06, IND-D-06 LOP-A-02, LOP-D-03 NEL-B-01, NEL-C-07, NEL-D-02 RIT-B-07, RIT-C-07 SAQ-B-01, SAQ-C-04, SAQ-D-03 TPR-A-07, TPR-B-04, TPR-B-06, TPR-C-05, TPR-D-02 ZZZ_3traj6us_every1ns.zip (3trajectories extended to 6microseconds or more) traj6us_every1ns/traj6us_every1ns_LIG-a-n.xtc IND-D-06, NEL-B-01, TPR-B-04 ZZZ_LigandBindingPosePDBs.zip (pickup 3 snapshots for each ligand) LigandBindingPosePDBs/LIG-a-n_frame.pdb movies_overlooking_28traj200ns.zip (7x2movies) movies_28traj200ns/movie_overlooking_LIG_28traj200ns-viewA.mp4 inspecting 28traj at once movies_28traj200ns/movie_overlooking_LIG_28traj200ns-viewB.mp4 from the opposite angle movies_1us.zip (17movies) movies_1us/movie_LIG-a-n_1us.mp4 movies_6us.zip (3movies) movies_6us/movie_LIG-a-n_6us.mp4 where LIG={DAR,IND,LOP,NEL,RIT,SAQ,TPR} DAR:darunavir IND:indinavir NEL:nelfinavir RIT:ritonavir SAQ:saquinavir TPR:tipranavir a={A,B,C,D} n={01,02,03,04,05,06,07}
drug repurposing, SARS-CoV-2, ligand binding, HIV inhibitor, COVID-19, all atom molecular dynamics simulation, molecular dynamics, Virus
drug repurposing, SARS-CoV-2, ligand binding, HIV inhibitor, COVID-19, all atom molecular dynamics simulation, molecular dynamics, Virus
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 2 | |
popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
views | 115 | |
downloads | 52 |